With 6,374 patents held between 2002 and 2022, Pfizer Inc holds the most number of Rare Diseases patents in the Chemicals sector in the Europe region.
The second largest number of patents were held by F. Hoffmann-La Roche Ltd with 3,928 Rare Diseases patents. The third largest number of patents were held by Johnson & Johnson with 3,400 Rare Diseases patents, of which 59.6% was contributed by Janssen Pharmaceutica NV. The fourth largest number of patents were held by Sanofi with 3,374 Rare Diseases patents. The fifth largest number of patents were held by AstraZeneca Plc with 2,875 Rare Diseases patents, of which 91.3% was contributed by AstraZeneca AB.
The top five patents holders, i.e., Pfizer Inc, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Sanofi, and AstraZeneca Plc, together held 19,951 Rare Diseases patents during the period.
Taiwan
Germany
United States of America
South Korea
United Kingdom
South Korea
Saudi Arabia
China
United Kingdom
Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.
Access more premium companies when you subscribe to Explorer
Contact the team or request a demo to find out how our data can drive your business forward